Cited by 3,481Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Open access

Gibb, W R, Lees, A J·1988·Journal of Neurology, Neurosurgery & Psychiatry

DOI 10.1136/jnnp.51.6.745PMC PMC1033142

Open this paper in CoChat — free account Open PDF

Abstract

The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jnnp.51.6.745

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 535
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & Langston, J. W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?
Kosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984) · PubMed · Cited by 401
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347
PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE
Duffy, P. E., & Tennyson, V. M. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 345
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
Gibb, W. R. G., & Lees, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 325
Self-citation
Esophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 305
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295

Show all 39 references

Research works printed but not linked: 7

Gibb WRG. The Lewy body and Parkinson's disease. In: Clifford Rose F, ed. Parkinson's Disease: Clinical and Experimental Advances. London: John Libbey and Co, 1987:3-11.
Oppenheimer D. Neuropathology of progressive autonomic failure. In: Bannister R, ed. Autonomic failure. Oxford University Press, London, 1983:267-83.
Sigwald J, Lapresle J, Raverdy P, Recondo NJ. Atrophie cerebelleuse familiale avec association de lesions nigeriennes et spinales. Presse Med 1964;72:557-62.
Vogt C, Vogt 0. Erkrankungen der GroBhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik. J Psychol Neurol 1922;28:1-171.
Hamada S, Ishii T. The Lewy body in the brain of the aged. Adv Neurol Sci 1963;7:184-6.
Hirai S. Ageing of the substantia nigra. Adv Neurol Sci 1968;12:845-9.
Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.

Sorted by citations

Items 901–1,000 of 1,022

Impairment of complex upper limb motor function in de novo Parkinson's disease
Ponsen, M. M., Daffertshofer, A., Wolters, E. C., Beek, P. J., & Berendse, H. W. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.07.019 · Cited by 67
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
Kim, J., Park, H. ‐., Park, I. ‐., Oh, Y., Ryu, D.-W., Song, I., Jung, Y. ‐., Yoo, I. R., Choi, H. ‐., Lee, P. H., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.13206 · Cited by 71
Quality of Life in Patients with Addison's Disease:
Riedel, M., Wiese, A. B., Schürmeyer, T. H., & Brabant, G. E. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211215 · Cited by 67
Exercise Therapies for Parkinson’s Disease: A Systematic Review and Meta-Analysis
Choi, H.-Y., Cho, K., Jin, C., Lee, J., Kim, T., Jung, W., Moon, S., Ko, C., Cho, S., Jeon, C., et al. (2020) · Parkinson s Disease · doi:10.1155/2020/2565320 · Cited by 66
Mitophagy and the Brain
Swerdlow, N., & Wilkins, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249661 · Cited by 66
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy
Gray, R. G., Patel, S., Ives, N. J., Rick, C., Woolley, R. L., Muzerengi, S., Gray, A. M., Jenkinson, C., McIntosh, E., Wheatley, K., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.4736 · Cited by 70
The spectrum of cognitive disorders in P arkinson's disease: A data‐driven approach
Dujardin, K., Leentjens, A. F. G., Langlois, C., Moonen, A. J. H., Duits, A., Carette, A., & Duhamel, A. (2013) · Movement Disorders · doi:10.1002/mds.25311 · Cited by 66
Bradykinesia-Akinesia Incoordination Test: Validating an Online Keyboard Test of Upper Limb Function
Noyce, A. J., Nagy, A., Acharya, S., Hadavi, S., Bestwick, J. P., Fearnley, J. M., Lees, A. J., & Giovannoni, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096260 · Cited by 66
Self-citation
Widespread Increase of Functional Connectivity in Parkinson’s Disease with Tremor: A Resting-State fMRI Study
Zhang, D., Liu, X., Chen, J., Liu, B., & Wang, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00006 · Cited by 68
The impact of and the factors associated with drooling in Parkinson's disease
Leibner, J., Ramjit, A. L., Sedig, L. K., Dai, Y. E., Wu, S. S., Jacobson, C. E., Okun, M. S., Rodriguez, R. L., Malaty, I. A., & Fernandez, H. H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.12.003 · Cited by 66
Lewy bodies in progressive supranuclear palsy
Mori, H., Oda, M., Komori, T., Arai, N., Takanashi, M., Mizutani, T., Hirai, S., & Mizuno, Y. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0555-3 · Cited by 66
Olfactory-induced brain activity in Parkinson's disease relates to the expression of event-related potentials: a functional magnetic resonance imaging study
Welge–Lüssen, A., Wattendorf, E., Schwerdtfeger, U., Fuhr, P., Bilecen, D., Hummel, T. R., & Westermann, B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.050 · Cited by 70
Non-invasive assessment of swallowing and respiration in Parkonson's disease
Pinnington, L., Muhiddin, K. A., Ellis, R. E., & Playford, E. D. (2000) · Journal of Neurology · doi:10.1007/s004150070091 · Cited by 66
Vascular pathology in patients with idiopathic Parkinson's disease
Rektor, I., Goldemund, D., Sheardová, K., Rektorová, I., Michálková, Z., & Dufek, M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.02.007 · Cited by 66
Diagnostic considerations in juvenile parkinsonism
Paviour, D. C., Surtees, R. A. H., & Lees, A. J. (2003) · Movement Disorders · doi:10.1002/mds.10644 · Cited by 66
Self-citation
A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort
Perez, F., Helmer, C., Dartigues, J. F., Auriacombe, S., & Tison, F. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.189142 · Cited by 66
Levodopa Therapy Monitoring in Patients With Parkinson Disease: a Kinetic–Dynamic Approach
Contin, M., Riva, R., Martinelli, P., Albani, F., Avoni, P., & Baruzzi, A. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200112000-00005 · Cited by 66
Effects of Physical Rehabilitation Integrated with Rhythmic Auditory Stimulation on Spatio-Temporal and Kinematic Parameters of Gait in Parkinson’s Disease
Pau, M., Corona, F., Pili, R., Casula, C., Sors, F., Agostini, T., Cossu, G., Guicciardi, M., & Murgia, M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00126 · Cited by 66
Altered Whole-Brain and Network-Based Functional Connectivity in Parkinson's Disease
de Schipper, L. J., Hafkemeijer, A., van der Grond, J., Marinus, J., Henselmans, J. M. L., & van Hilten, J. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00419 · Cited by 68
Novel parkin mutations detected in patients with early‐onset Parkinson's disease
Bertoli‐Avella, A. M., Giroud‐Benitez, J. L., Akyol, A., Barbosa, E. R., Schaap, O., van der Linde, H. C., Martignoni, E., Lopiano, L., Lamberti, P., Fincati, E., et al. (2004) · Movement Disorders · doi:10.1002/mds.20343 · Cited by 66
Nocturnal body core temperature falls in Parkinson's disease but not in multiple‐system atrophy
Pierangeli, G., Provini, F., Maltoni, P., Barletta, G., Contin, M., Lugaresi, E., Montagna, P., & Cortelli, P. (2001) · Movement Disorders · doi:10.1002/mds.1039 · Cited by 66
Loss of long-duration response to levodopa over time in PD
Zappia, M., Oliveri, R. L., Montesanti, R., Rizzo, M., Bosco, D., Plastino, M., Crescibene, L., Bastone, L., Aguglia, U., Gambardella, A., et al. (1999) · Neurology · doi:10.1212/wnl.52.4.763 · Cited by 65
Rescue of α-synuclein cytotoxicity by insulin-like growth factors
Kao, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.089 · Cited by 65
Comparison of office‐based versus home web‐based clinical assessments for Parkinson's disease
Cubo, E., Trejo-Gabriel-Galan, J. M., Seco, J., Alcubilla, C. R., Yang, C., Fernández-Arconada, O., & Pérez, N. M. (2011) · Movement Disorders · doi:10.1002/mds.24028 · Cited by 65
T1rho (T1ρ) MR imaging in Alzheimer’ disease and Parkinson’s disease with and without dementia
Haris, M., Singh, A. K., Cai, K., Davatzikos, C. A., Trojanowski, J. Q., Melhem, E. R., Clark, C. M., & Borthakur, A. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5762-6 · Cited by 65
Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up
Bannier, S., Montaurier, C., Derost, P. P., Ulla, M., Lemaire, J., Boirie‌, Y., Morio, B., & Durif, F. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.158576 · Cited by 65
Patterns of motor and non-motor features in Parkinson's disease
van Rooden, S. M., Jeukens‐Visser, M., Verbaan, D., Marinus, J., & van Hilten, J. J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.166629 · Cited by 65
Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease
Herd, C. P., Tomlinson, C. L., Deane, K. H., Brady, M., Smith, C. H., Sackley, C. M., & Clarke, C. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002812.pub2 · Cited by 65
Genetic association between α‐synuclein and idiopathic parkinson's disease
Kay, D. M., Factor, S. A., Samii, A., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Nutt, J. G., Montimurro, J. S., Keefe, R. G., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30758 · Cited by 65
Increased weighting on prior knowledge in Lewy body-associated visual hallucinations
Zarkali, A., Adams, R. A., Psarras, S., Leyland, L., Rees, G. E., & Weil, R. S. (2019) · Brain Communications · doi:10.1093/braincomms/fcz007 · Cited by 65
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Baldacci, F., Mazzucchi, S., Vecchia, A. D., Giampietri, L., Giannini, N., Koronyo‐Hamaoui, M., Ceravolo, R., Siciliano, G., Bonuccelli, U., Elahi, F. M., et al. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731306 · Cited by 65
Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction
Zarkali, A., McColgan, P., Leyland, L.-A., Lees, A., Rees, G., & Weil, R. (2020) · Neurology · doi:10.1212/wnl.0000000000009014 · Cited by 67
Self-citation
The subacute levodopa test for evaluating long‐duration response in parkinson's disease
Quattrone, A., Zappia, M., Aguglia, U., Branca, D., Colao, R., Montesanti, R., Nicoletti, G., Palmieri, A., Parlato, G., & Rizzo, M. (1995) · Annals of Neurology · doi:10.1002/ana.410380308 · Cited by 65
Clinical Correlates of Apathy in Patients Recently Diagnosed with Parkinson’s Disease: The ANIMO Study
Cubo, E., Benito‐León, J., Coronell, C., Armesto, D., & on behalf of the ANIMO Study Group (2012) · Neuroepidemiology · doi:10.1159/000334314 · Cited by 64
Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease
Baik, K., Jung, J. H., Jeong, S. H., Chung, S. J., Yoo, H. S., Lee, P. H., Sohn, Y. H., Kang, S. W., & Ye, B. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-21951-5 · Cited by 64
Pareidolia in Parkinson's disease without dementia: A positron emission tomography study
Uchiyama, M., Nishio, Y., Yokoi, K., Hosokai, Y., Takeda, A., & Mori, E. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.03.020 · Cited by 64
Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria
Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 64
Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms
Pinkhardt, E. H., Jürgens, R., Lulé, D. E., Heimrath, J., Ludolph, A. C., Becker, W., & Kassubek, J. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-5 · Cited by 64
Effects of Donepezil on Central Processing Speed and Attentional Measures in Parkinson’s Disease with Dementia and Dementia with Lewy Bodies
Rowan, E. N., McKeith, I. G., Saxby, B. K., O'Brien, J. T., Burn, D. J., Mosimann, U. P., Newby, J., Daniel, S., Sanders, J., & Wesnes, K. A. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000098335 · Cited by 64
Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease
Pinkhardt, E. H., Kassubek, J., Süßmuth, S. D., Ludolph, A. C., Becker, W., & Jürgens, R. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5131-5 · Cited by 64
[123I]FP‐CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes
Hauser, R. A., & Grosset, D. G. (2011) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00583.x · Cited by 64
The 39-item Parkinson's Disease Questionnaire (PDQ-39): is it a unidimensional construct?
Hagell, P., & Nilsson, M. H. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609103726 · Cited by 68
Factors associated with depression in Parkinson’s disease: a cross-sectional study in a Polish population
Wichowicz, H., Sławek, J. W., Derejko, M., & Cubała, W. J. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.01.012 · Cited by 64
Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease
Chagas, M. H. N., Tumas, V., Rodrigues, G. R., Machado‐de‐Sousa, J. P., Filho, A. S., Hallak, J. E. C., & Crippa, J. A. S. (2013) · Age and Ageing · doi:10.1093/ageing/aft065 · Cited by 64
Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour
Abe, N., Fujii, T., Hirayama, K., Takeda, A., Hosokai, Y., Ishioka, T., Nishio, Y., Suzuki, K., Itoyama, Y., Takahashi, S., et al. (2009) · Brain · doi:10.1093/brain/awp052 · Cited by 66
Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis
Ragland, M. F., Hutter, C., Zabetian, C. P., & Edwards, K. L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp288 · Cited by 64
Parkinson’s disease and occupational exposures: a systematic literature review and meta-analyses
Gunnarsson, L., & Bodin, L. (2017) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.3641 · Cited by 71
Increased alpha activity in REM sleep in de novo patients with Parkinson's disease
Wetter, T. C., Brünner, H., Högl, B., Yassouridis, A., Trenkwalder, C., & Frieß, E. (2001) · Movement Disorders · doi:10.1002/mds.1163 · Cited by 64
Motor imagery in normal subjects and Parkinson's disease patients: an H215O PET study
Samuel, M., Ceballos-Baumann, A., Boecker, H., & Brooks, D. J. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00040 · Cited by 64
Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology
Wakabayashi, K., Fukushima, T., Koide, R., Horikawa, Y., Hasegawa, M., Watanabe, Y., Noda, T., Eguchi, I., Morita, T., Yoshimoto, M., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010050049 · Cited by 64
Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease
Pinkhardt, E. H., Jürgens, R., Becker, W., Valdarno, F., Ludolph, A. C., & Kassubek, J. (2008) · Journal of Neurology · doi:10.1007/s00415-009-0027-y · Cited by 66
Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction
VanItallie, T. B. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.015 · Cited by 64
Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease
Rektorová, I., Barrett, J., Mikl, M., Rektor, I., & Paus, T. (2007) · Movement Disorders · doi:10.1002/mds.21548 · Cited by 65
The significance of motor (A)symmetry in Parkinson's disease
Marinus, J., & van Hilten, J. J. (2014) · Movement Disorders · doi:10.1002/mds.26107 · Cited by 63
Effect of environmental toxicants on neuronal functions
Sharma, S., Wakode, S. R., Sharma, A., Nair, N., Dhobi, M., Wani, M. A., & Pottoo, F. H. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-10950-6 · Cited by 69
Evaluation of mild cognitive impairment subtypes in Parkinson's disease
Cholerton, B., Zabetian, C. P., Wan, J. Y., Montine, T. J., Quinn, J. F., Mata, I. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., et al. (2014) · Movement Disorders · doi:10.1002/mds.25875 · Cited by 63
Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson’s disease
Sedláčková, S., Rektorová, I., Srovnalová, H., & Rektor, I. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0259-0 · Cited by 63
A novel method for systematic analysis of rigidity in Parkinson's disease
Endo, T., Okuno, R., Yokoe, M., Akazawa, K., & Sakoda, S. (2009) · Movement Disorders · doi:10.1002/mds.22752 · Cited by 63
Camptocormia in Parkinson's Disease
Abe, K., Uchida, Y., & Notani, M. (2010) · Parkinson s Disease · doi:10.4061/2010/267640 · Cited by 63
Is D ominant‐ S ide O nset A ssociated W ith a B etter M otor C ompensation in P arkinson's D isease?
Ham, J. H., Lee, J. J., Kim, J. S., Lee, P. H., & Sohn, Y. H. (2015) · Movement Disorders · doi:10.1002/mds.26418 · Cited by 63
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
Kang, U. J., Goldman, J. G., Alcalay, R. N., Xie, T., Tuite, P., Henchcliffe, C., Hogarth, P., Amara, A. W., Frank, S., Rudolph, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26613 · Cited by 63
Clinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease
Liu, F., Ge, J., Wu, J.-J., Wu, P., Ma, Y., Zuo, C., & Wang, J. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002148 · Cited by 63
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy
Clarke, C. E., & Lowry, M. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00111.x · Cited by 63
Cognitive recovery instead of decline after acute encephalitis: a prospective follow up study
Hokkanen, L., & Launes, J. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.2.222 · Cited by 63
How to treat Parkinson’s disease in 2013
Worth, P. F. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-1-93 · Cited by 62
Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
Giusto, E., Yacoubian, T. A., Greggio, E., & Civiero, L. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00230-6 · Cited by 63
Enrichment of extracellular vesicles using Mag-Net for the analysis of the plasma proteome
Wu, C. C., Tsantilas, K. A., Park, J., Plubell, D. L., Sanders, J. A., Naicker, P., Govender, I. S., Buthelezi, S. G., Stoychev, S., Jordaan, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60595-7 · Cited by 121
Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients
Lehrner, J. P., Moser, D., Klug, S., Gleiß, A., Auff, E., Pirker, W., & Pußwald, G. (2014) · European Journal of Neurology · doi:10.1111/ene.12470 · Cited by 65
Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
Marx, S., Respondek, G., Stamelou, M., Dowiasch, S., Stoll, J., Bremmer, F., Oertel, W. H., Höglinger, G. U., & Einhäuser, W. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00088 · Cited by 64
The P3a wave: A reliable neurophysiological measure of Parkinson’s disease duration and severity
Solís‐Vivanco, R., Rodríguez‐Violante, M., Rodríguez‐Agudelo, Y., Schilmann, A., Rodríguez-Ortiz, U., & Ricardo-Garcell, J. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.12.024 · Cited by 62
Facilitated temporal summation of pain at spinal level in Parkinson's disease
Perrotta, A., Sandrini, G., Serrao, M., Buscone, S., Tassorelli, C., Tinazzi, M., Zangaglia, R., Pacchetti, C., Bartolo, M., Pierelli, F., et al. (2010) · Movement Disorders · doi:10.1002/mds.23458 · Cited by 62
Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease
Uchida, A., Pillai, J. A., Bermel, R. A., Bonner‐Jackson, A., Rae-Grant, A. D., Fernandez, H. H., Bena, J., Jones, S. E., Leverenz, J. B., Srivastava, S. K., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23240 · Cited by 62
Olfactory dysfunction in Alzheimer's disease– and Lewy body–related cognitive impairment
Yoo, H. S., Jeon, S., Chung, S. J., Yun, M., Lee, P. H., Sohn, Y. H., Evans, A. C., & Ye, B. S. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.010 · Cited by 62
Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus
Pinter, M. M., Alesch, F., Murg, M., Helscher, R. J., & Binder, H. (1999) · Journal of Neurology · doi:10.1007/s004150050481 · Cited by 62
Occupations and Parkinson’s Disease: A Multi-Center Case-Control Study in South Korea
Park, J., Yoo, C., Sim, C. S., Kim, H.-K., Kim, J. W., Jeon, B. S., Kim, K.-R., Bang, O.-Y., Lee, W.-Y., Yi, Y., et al. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.07.001 · Cited by 62
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Parkinson's disease is not associated with the combined α‐synuclein/apolipoprotein E susceptibility genotype
Khan, N. L., Graham, E., Dixon, P. H., Morris, C. M., Mander, A., Clayton, D. G., Vaughan, J. R., Quinn, N. P., Lees, A. J., Daniel, S. E., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1027 · Cited by 62
Self-citation
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Shin, H., Hong, S.-W., & Youn, Y. C. (2022) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.18.3.259 · Cited by 72
Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia
Zoccolella, S., Dell’Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Canesi, M., Cristina, S., Marchese, R., Pacchetti, C., Zagaglia, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22511 · Cited by 65
Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson’s Disease
Cersosimo, M. G. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/476041 · Cited by 63
Dysfunction of bulbar central pattern generator in ALS patients with dysphagia during sequential deglutition
Aydogdu, I., Tanrıverdi, Z., & Erteki̇n, C. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2010.11.002 · Cited by 61
Cognitive and SPECT characteristics predict progression of Parkinson?s disease in newly diagnosed patients
Dujardin, K., Defebvre, L., Duhamel, A., Lecouffe, P., Rogelet, P., Steinling, M., & Dest�e, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0549-2 · Cited by 60
Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients
Plomhause, L., Dujardin, K., Duhamel, A., Delliaux, M., Derambure, P., Defebvre, L., & Charley, C. M. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.04.018 · Cited by 61
Automated Computer Differential Classification in Parkinsonian Syndromes via Pattern Analysis on MRI
Duchesne, S., Rolland, Y., & Vérin, M. (2008) · Academic Radiology · doi:10.1016/j.acra.2008.05.024 · Cited by 64
Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease
Kallio, M., Korpelainen, J. T., Tolonen, U., Sotaniemi, K. A., Myllyl�, V. V., Haapaniemi, T., & Suominen, K. (2000) · Journal of Neurology · doi:10.1007/s004150070075 · Cited by 61
Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder
Kim, J., Park, H.-E., Oh, Y., Lee, S., Park, J., Son, B.-C., & Lee, K.-S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.020 · Cited by 61
The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future
Schilder, J. C. M., Overmars, S. S., Marinus, J., van Hilten, J. J., & Koehler, P. J. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.01.010 · Cited by 61
GBA -Associated Parkinson’s Disease: Progression in a Deep Brain Stimulation Cohort
Lythe, V., Athauda, D. S., Foley, J. A., Mencacci, N. E., Jahanshahi, M., Cipolotti, L., Hyam, J. A., Zrinzo, L. U., Hariz, M. I., Hardy, J., et al. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171172 · Cited by 64
Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease
Guttuso, T. J., Bergsland, N., Hagemeier, J., Lichter, D. G., Pasternak, O., & Zivadinov, R. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5545 · Cited by 61
Acute Challenge with Apomorphine and Levodopa in Parkinsonism
Rossi, P., Colosimo, C., Moro, E., Tonali, P. A., & Albanese, A. (2000) · European Neurology · doi:10.1159/000008142 · Cited by 61
The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease
Colloby, S. J., O'Brien, J. T., Fenwick, J. D., Firbank, M., Burn, D. J., McKeith, I. G., & Williams, E. D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.045 · Cited by 59
Event‐Related desynchronization to contingent negative variation and Self‐Paced movement paradigms in Parkinson's disease
Magnani, G., Cursi, M., Leocani, L., Volonté, M. A., Locatelli, T., Elia, A., & Comi, G. (1998) · Movement Disorders · doi:10.1002/mds.870130408 · Cited by 61
Sympathetic skin response and R‐R interval variability in multipele system atrophy and idiopathic Parkinson's disease
Bordet, R., Benhadjali, J., Destée, A., Hurtevent, J. F., Bourriez, J. L., & Guieu, J. D. (1996) · Movement Disorders · doi:10.1002/mds.870110309 · Cited by 61
Pilot safety and feasibility study of treadmill aerobic exercise in Parkinson disease with gait impairment
Skidmore, F. M. (2008) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2006.10.0130 · Cited by 60
Prevalence of Parkinson’s disease and atypical parkinsonian syndromes in a rural Japanese district
Osaki, Y., Morita, Y., Kuwahara, T., Miyano, I., & Doi, Y. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01442.x · Cited by 62
Inhibitory motor dysfunction in parkinson's disease subtypes
Gong, T., Xiang, Y., Saleh, M. G., Gao, F., Chen, W., Edden, R. A. E., & Wang, G. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25865 · Cited by 44
Prospective study on cost-effectiveness of home-based motor assessment in Parkinson’s disease
Cubo, E., Mariscal, N., Solano, B., Becerra, V, Armesto, D., Calvo, S., Arribas, J., Seco, J., Martinez, A., Zorrilla, L., et al. (2017) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16638971 · Cited by 45
Beneficial Therapeutic Effects of Spinal Cord Stimulation in Advanced Cases of Parkinson’s Disease With Intractable Chronic Pain: A Case Series
Nishioka, K., & Nakajima, M. (2015) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12315 · Cited by 44
Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future
Hu, M.-L., Pan, Y.-R., Yong, Y.-Y., Liu, Y., Yu, L., Qin, D.-L., Qiao, G., Law, B. Y.-K., Wu, J.-M., Zhou, X.-G., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102078 · Cited by 44
Ceftriaxone Protects Astrocytes from MPP+ via Suppression of NF-ΚB/JNK/c-Jun Signaling
Zhang, Y., Zhang, X., & Qu, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8845-z · Cited by 39

Authors: Gibb, W. R., & Lees, A. J.
ORCID: Gibb, W R
Lees, A J
Venue: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Published: 1988-06-01
Volume: 51
Issue: 6
Pages: 745-752
ISSN: 0022-3050 (ISSN-L)
DOI: 10.1136/jnnp.51.6.745
PMC: PMC1033142
OpenAlex: W2132881915
Semantic Scholar: 354cd1cf28ad23a8038bb3c576ff7791b3c74543
Cited by: 3,481
References: 39
Citations by year: 2026: 78 · 2025: 130 · 2024: 152 · 2023: 143 · 2022: 131 · 2021: 158 · 2020: 164 · 2019: 152 · 2018: 138 · 2017: 156 · 2016: 163 · 2015: 115 · 2014: 149 · 2013: 123 · 2012: 138
FWCI: 3.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Lewy bodies, Parkinson's disease, pathogenesis, neurofilaments, substantia nigra, incidental Lewy body disease, age-related prevalence, neuronal loss
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Brain, Brain Damage, Chronic, Inclusion Bodies, Child, Humans, Middle Aged, Nerve Degeneration, Parkinson Disease, Substantia Nigra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks